Markets:

Overview

News

Currencies

International

Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

75.43 +0.29 (+0.39%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hologic, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Peering Into Hologic's Recent Short Interest ↗

November 27, 2024

Via Benzinga

Looking Into Hologic's Recent Short Interest ↗

November 06, 2024

Via Benzinga

Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday? ↗

November 04, 2024

The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday.

Via Benzinga

Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints ↗

October 25, 2024

FDA and Hologic advise health providers to return all unused BioZorb Markers due to adverse events, including pain and infection.

Via Benzinga

Topics Product Recall

Assessing Hologic: Insights From 10 Financial Analysts ↗

October 04, 2024

Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today ↗

September 30, 2024

Via Benzinga

Critical Insights From Hologic Analyst Ratings: What You Need To Know ↗

September 17, 2024

Via Benzinga

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments ↗

October 14, 2024

Hologic Inc. is acquiring Gynesonics for $350 million, adding the Sonata System to its fibroid treatment lineup. The acquisition aims to boost Hologic's women's health offerings and expand minimally...

Via Benzinga

Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years ↗

September 12, 2024

Via Benzinga

Peering Into Hologic's Recent Short Interest ↗

September 02, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Years ↗

August 19, 2024

Via Benzinga

Analyst Scoreboard: 8 Ratings For Hologic ↗

August 16, 2024

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Today ↗

August 06, 2024

Via Benzinga

GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

July 30, 2024

Via Benzinga

Hologic Analysts Boost Their Forecasts After Q3 Results ↗

July 30, 2024

Via Benzinga

The Analyst Verdict: Hologic In The Eyes Of 8 Experts ↗

July 30, 2024

Via Benzinga

Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday? ↗

July 30, 2024

Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings reports and the Federal Open Market Committee meeting.

Via Benzinga

HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q3 2024 ↗

July 29, 2024

HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today ↗

July 25, 2024

Via Benzinga

Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today ↗

July 15, 2024

Via Benzinga

Peering Into Hologic's Recent Short Interest ↗

July 01, 2024

Via Benzinga

Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday? ↗

July 29, 2024

Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events.

Via Benzinga

Topics Economy

Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation

July 12, 2024

Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation

Via News Direct

Topics Lawsuit

Women's Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says ↗

June 27, 2024

Stephens initiated coverage on Hologic, highlighting its strong position in women's health and molecular diagnostics. Known for robust revenue growth and attractive profit margins, Hologic is set for...

Via Benzinga

Analyst Scoreboard: 7 Ratings For Hologic ↗

June 27, 2024

Via Benzinga

Deep Dive Into Hologic Stock: Analyst Perspectives (4 Ratings) ↗

May 03, 2024

Via Benzinga

The Analyst Landscape: 4 Takes On Hologic ↗

April 03, 2024

Via Benzinga

3 Online Sports Betting Stocks That Look Like Likely Winners ↗

June 27, 2024

After billionaire Carl Icahn invested in Caesars, retail investors should also buy sports betting stocks. Here are three top names.

Via InvestorPlace

This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

June 27, 2024

Via Benzinga

HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024 ↗

May 02, 2024

HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hologic, Inc. - Common Stock (NQ:HOLX)

Headline News about Hologic, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today